LEVOKETOCONAZOLE IN THE TREATMENT OF ENDOGENOUS CUSHING'S SYNDROME: IMPROVEMENTS IN CLINICAL SIGNS AND SYMPTOMS, PATIENT-REPORTED OUTCOMES, AND ASSOCIATED BIOCHEMICAL MARKERS IN THE PHASE 3 SONICS STUDY
AACE ePoster Library. Fleseriu M. 04/25/19; 262780; 597966
Dr. Maria Fleseriu
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}